PubMed:32571880
Annnotations
LitCovid-OGER-BB
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 60-69 | GO:0005840 | denotes | ribosomal |
| T2 | 70-87 | SO:0001532 | denotes | frameshift signal |
| T3 | 91-95 | SP_10 | denotes | SARS |
| T4 | 91-95 | PR:000014459 | denotes | SARS |
| T5 | 96-107 | NCBITaxon:11118 | denotes | coronavirus |
| T6 | 111-115 | PR:000014459 | denotes | SARS |
| T7 | 111-121 | SP_7 | denotes | SARS-CoV-2 |
| T8 | 149-194 | SP_10 | denotes | severe acute respiratory syndrome coronavirus |
| T9 | 162-173 | UBERON:0001004 | denotes | respiratory |
| T10 | 196-204 | SP_10 | denotes | SARS-CoV |
| T11 | 250-258 | SP_7 | denotes | COVID-19 |
| T12 | 278-282 | SP_10 | denotes | SARS |
| T13 | 283-294 | NCBITaxon:11118 | denotes | coronavirus |
| T14 | 298-308 | SP_7 | denotes | SARS-CoV-2 |
| T15 | 344-355 | GO:0042995 | denotes | projections |
| T16 | 464-469 | NCBITaxon:10239 | denotes | virus |
| T17 | 497-505 | CHEBI:36357 | denotes | molecule |
| T18 | 497-505 | CHEBI:36357 | denotes | molecule |
| T19 | 531-544 | NCBITaxon:11118 | denotes | coronaviruses |
| T20 | 596-605 | GO:0005840 | denotes | ribosomal |
| T21 | 629-636 | GO:0065007 | denotes | control |
| T22 | 650-660 | GO:0010467 | denotes | expression |
| T23 | 701-709 | SP_10 | denotes | SARS-CoV |
| T24 | 856-859 | GO:0035098 | denotes | PRF |
| T25 | 893-896 | GO:0035098 | denotes | PRF |
| T26 | 914-919 | NCBITaxon:10239 | denotes | virus |
| T27 | 914-919 | GO:0006260 | denotes | virus |
| T28 | 920-931 | GO:0006260 | denotes | replication |
| T29 | 1032-1040 | SP_10 | denotes | SARS-CoV |
| T30 | 1045-1055 | SP_7 | denotes | SARS-CoV-2 |
| T31 | 1253-1263 | SO:0000591 | denotes | pseudoknot |
| T32 | 1335-1342 | SO:0000313 | denotes | hairpin |
| T33 | 1390-1397 | NCBITaxon:10239 | denotes | viruses |
| T34 | 1516-1527 | SO:0000591 | denotes | pseudoknots |
| T35 | 1531-1539 | SP_10 | denotes | SARS-CoV |
| T36 | 1544-1554 | SP_7 | denotes | SARS-CoV-2 |
| T37 | 1600-1608 | CHEBI:36357 | denotes | molecule |
| T38 | 1600-1608 | CHEBI:36357 | denotes | molecule |
| T39 | 1638-1646 | SP_10 | denotes | SARS-CoV |
| T40 | 1719-1729 | SP_7 | denotes | SARS-CoV-2 |
| T41 | 1763-1773 | CHEBI:35222 | denotes | inhibitors |
| T42 | 1763-1773 | CHEBI:35222 | denotes | inhibitors |
| T43 | 1796-1805 | CHEBI:36357 | denotes | compounds |
| T44 | 1796-1805 | CHEBI:36357 | denotes | compounds |
| T45 | 1828-1836 | SP_7 | denotes | COVID-19 |
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T1 | 60-69 | Body_part | denotes | ribosomal | http://purl.org/sig/ont/fma/fma66867 |
| T2 | 596-605 | Body_part | denotes | ribosomal | http://purl.org/sig/ont/fma/fma66867 |
| T3 | 670-678 | Body_part | denotes | proteins | http://purl.org/sig/ont/fma/fma67257 |
| T4 | 776-780 | Body_part | denotes | mRNA | http://purl.org/sig/ont/fma/fma67122 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T1 | 91-95 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T2 | 111-119 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T3 | 149-182 | Disease | denotes | severe acute respiratory syndrome | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T4 | 196-204 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T5 | 250-258 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T6 | 278-282 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T7 | 298-306 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T8 | 701-709 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T9 | 1032-1040 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T10 | 1045-1053 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T11 | 1531-1539 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T12 | 1544-1552 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T13 | 1638-1646 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T14 | 1719-1727 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T15 | 1828-1836 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 81-87 | http://purl.obolibrary.org/obo/SO_0000418 | denotes | signal |
| T2 | 239-249 | http://purl.obolibrary.org/obo/UBERON_0001456 | denotes | facing the |
| T3 | 380-381 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T4 | 398-399 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T5 | 464-469 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
| T6 | 553-554 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T7 | 740-741 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T8 | 851-852 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T9 | 897-905 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activity |
| T10 | 914-919 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
| T11 | 954-962 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activity |
| T12 | 1067-1074 | http://purl.obolibrary.org/obo/SO_0000418 | denotes | signals |
| T13 | 1287-1295 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activity |
| T14 | 1343-1351 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activity |
| T15 | 1390-1397 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | viruses |
| T16 | 1592-1593 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T1 | 497-505 | Chemical | denotes | molecule | http://purl.obolibrary.org/obo/CHEBI_25367 |
| T2 | 670-678 | Chemical | denotes | proteins | http://purl.obolibrary.org/obo/CHEBI_36080 |
| T3 | 1600-1608 | Chemical | denotes | molecule | http://purl.obolibrary.org/obo/CHEBI_25367 |
| T4 | 1763-1773 | Chemical | denotes | inhibitors | http://purl.obolibrary.org/obo/CHEBI_35222 |
| T5 | 1791-1805 | Chemical | denotes | lead compounds | http://purl.obolibrary.org/obo/CHEBI_33585 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 2 | 91-109 | Species | denotes | SARS coronavirus 2 | Tax:2697049 |
| 3 | 111-121 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
| 18 | 149-194 | Species | denotes | severe acute respiratory syndrome coronavirus | Tax:694009 |
| 19 | 196-204 | Species | denotes | SARS-CoV | Tax:694009 |
| 20 | 250-258 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 21 | 283-294 | Species | denotes | coronavirus | Tax:11118 |
| 22 | 298-308 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
| 23 | 531-544 | Species | denotes | coronaviruses | Tax:11118 |
| 24 | 701-709 | Species | denotes | SARS-CoV | Tax:694009 |
| 25 | 1032-1040 | Species | denotes | SARS-CoV | Tax:694009 |
| 26 | 1045-1055 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
| 27 | 1531-1539 | Species | denotes | SARS-CoV | Tax:694009 |
| 28 | 1544-1554 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
| 29 | 1638-1646 | Species | denotes | SARS-CoV | Tax:694009 |
| 30 | 1719-1729 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
| 31 | 1828-1836 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-123 | Sentence | denotes | Structural and functional conservation of the programmed -1 ribosomal frameshift signal of SARS coronavirus 2 (SARS-CoV-2). |
| T2 | 124-310 | Sentence | denotes | About 17 years after the severe acute respiratory syndrome coronavirus (SARS-CoV) epidemic, the world is currently facing the COVID-19 pandemic caused by SARS coronavirus 2 (SARS-CoV-2). |
| T3 | 311-526 | Sentence | denotes | According to the most optimistic projections, it will take more than a year to develop a vaccine, so the best short-term strategy may lie in identifying virus-specific targets for small molecule-based interventions. |
| T4 | 527-679 | Sentence | denotes | All coronaviruses utilize a molecular mechanism called programmed -1 ribosomal frameshift (-1 PRF) to control the relative expression of their proteins. |
| T5 | 680-880 | Sentence | denotes | Previous analyses of SARS-CoV have revealed that it employs a structurally unique three-stemmed mRNA pseudoknot that stimulates high -1 PRF rates and that it also harbors a -1 PRF attenuation element. |
| T6 | 881-995 | Sentence | denotes | Altering -1 PRF activity impairs virus replication, suggesting that this activity may be therapeutically targeted. |
| T7 | 996-1075 | Sentence | denotes | Here, we comparatively analyzed the SARS-CoV and SARS-CoV-2 frameshift signals. |
| T8 | 1076-1296 | Sentence | denotes | Structural and functional analyses revealed that both elements promote similar -1 PRF rates and that silent coding mutations in the slippery sites and in all three stems of the pseudoknot strongly ablate -1 PRF activity. |
| T9 | 1297-1458 | Sentence | denotes | We noted that the upstream attenuator hairpin activity is also functionally retained in both viruses, despite differences in the primary sequence in this region. |
| T10 | 1459-1582 | Sentence | denotes | Small-angle X-ray scattering analyses indicated that the pseudoknots in SARS-CoV and SARS-CoV-2 have the same conformation. |
| T11 | 1583-1846 | Sentence | denotes | Finally, a small molecule previously shown to bind the SARS-CoV pseudoknot and inhibit -1 PRF was similarly effective against -1 PRF in SARS-CoV-2, suggesting that such frameshift inhibitors may be promising lead compounds to combat the current COVID-19 pandemic. |
LitCovid_AGAC_only
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| p40518s0 | 881-889 | Var | denotes | Altering |
| p40518s5 | 906-913 | NegReg | denotes | impairs |
| p40518s6 | 914-919 | Protein | denotes | virus |
| p40518s7 | 920-931 | MPA | denotes | replication |
sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-123 | Sentence | denotes | Structural and functional conservation of the programmed -1 ribosomal frameshift signal of SARS coronavirus 2 (SARS-CoV-2). |
| T2 | 124-310 | Sentence | denotes | About 17 years after the severe acute respiratory syndrome coronavirus (SARS-CoV) epidemic, the world is currently facing the COVID-19 pandemic caused by SARS coronavirus 2 (SARS-CoV-2). |
| T3 | 311-526 | Sentence | denotes | According to the most optimistic projections, it will take more than a year to develop a vaccine, so the best short-term strategy may lie in identifying virus-specific targets for small molecule-based interventions. |
| T4 | 527-679 | Sentence | denotes | All coronaviruses utilize a molecular mechanism called programmed -1 ribosomal frameshift (-1 PRF) to control the relative expression of their proteins. |
| T5 | 680-880 | Sentence | denotes | Previous analyses of SARS-CoV have revealed that it employs a structurally unique three-stemmed mRNA pseudoknot that stimulates high -1 PRF rates and that it also harbors a -1 PRF attenuation element. |
| T6 | 881-995 | Sentence | denotes | Altering -1 PRF activity impairs virus replication, suggesting that this activity may be therapeutically targeted. |
| T7 | 996-1075 | Sentence | denotes | Here, we comparatively analyzed the SARS-CoV and SARS-CoV-2 frameshift signals. |
| T8 | 1076-1296 | Sentence | denotes | Structural and functional analyses revealed that both elements promote similar -1 PRF rates and that silent coding mutations in the slippery sites and in all three stems of the pseudoknot strongly ablate -1 PRF activity. |
| T9 | 1297-1458 | Sentence | denotes | We noted that the upstream attenuator hairpin activity is also functionally retained in both viruses, despite differences in the primary sequence in this region. |
| T10 | 1459-1582 | Sentence | denotes | Small-angle X-ray scattering analyses indicated that the pseudoknots in SARS-CoV and SARS-CoV-2 have the same conformation. |
| T11 | 1583-1846 | Sentence | denotes | Finally, a small molecule previously shown to bind the SARS-CoV pseudoknot and inhibit -1 PRF was similarly effective against -1 PRF in SARS-CoV-2, suggesting that such frameshift inhibitors may be promising lead compounds to combat the current COVID-19 pandemic. |
Glycosmos6-MAT
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 768-775 | http://purl.obolibrary.org/obo/MAT_0000239 | denotes | stemmed |
| T2 | 1240-1245 | http://purl.obolibrary.org/obo/MAT_0000239 | denotes | stems |
Anatomy-MAT
| Id | Subject | Object | Predicate | Lexical cue | mat_id |
|---|---|---|---|---|---|
| T1 | 768-775 | Body_part | denotes | stemmed | http://purl.obolibrary.org/obo/MAT_0000239 |
| T2 | 1240-1245 | Body_part | denotes | stems | http://purl.obolibrary.org/obo/MAT_0000239 |
mondo_disease
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T1 | 91-95 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T2 | 111-121 | Disease | denotes | SARS-CoV-2 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T3 | 149-182 | Disease | denotes | severe acute respiratory syndrome | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T4 | 196-204 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T5 | 250-258 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T6 | 278-282 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T7 | 298-308 | Disease | denotes | SARS-CoV-2 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T8 | 701-709 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T9 | 1032-1040 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T10 | 1045-1055 | Disease | denotes | SARS-CoV-2 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T11 | 1531-1539 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T12 | 1544-1554 | Disease | denotes | SARS-CoV-2 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T13 | 1638-1646 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T14 | 1719-1729 | Disease | denotes | SARS-CoV-2 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T15 | 1828-1836 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
NCBITAXON
| Id | Subject | Object | Predicate | Lexical cue | db_id |
|---|---|---|---|---|---|
| T1 | 111-119 | OrganismTaxon | denotes | SARS-CoV | 694009 |
| T2 | 149-182 | OrganismTaxon | denotes | severe acute respiratory syndrome | 694009 |
| T3 | 196-204 | OrganismTaxon | denotes | SARS-CoV | 694009 |
| T4 | 298-306 | OrganismTaxon | denotes | SARS-CoV | 694009 |
| T5 | 701-709 | OrganismTaxon | denotes | SARS-CoV | 694009 |
| T6 | 1032-1040 | OrganismTaxon | denotes | SARS-CoV | 694009 |
| T7 | 1045-1053 | OrganismTaxon | denotes | SARS-CoV | 694009 |
| T8 | 1531-1539 | OrganismTaxon | denotes | SARS-CoV | 694009 |
| T9 | 1544-1552 | OrganismTaxon | denotes | SARS-CoV | 694009 |
| T10 | 1638-1646 | OrganismTaxon | denotes | SARS-CoV | 694009 |
| T11 | 1719-1727 | OrganismTaxon | denotes | SARS-CoV | 694009 |